Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This study is designed and aimed at determine the clinical efficacy of BoNT-A on patients
with dysfunctional voiding. The results of this study can provide further information for
patient selection and therapeutic duration.
Phase:
Phase 2
Details
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA